The Patent Finder

Terms ending in 2030

Eyepoint, Inc.

Every in-force patent on Eyepoint, Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,569,348Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells
In force
 · High confidence
Eyepoint, Inc.In forceHigh confidence
US 8,883,832Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells
In force
 · High confidence
Eyepoint, Inc.In forceHigh confidence
US 9,174,950Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells
In force
 · High confidence
Eyepoint, Inc.In forceHigh confidence
US 9,949,956Compounds, Compositions, and Methods for Preventing Metasasis of Cancer Cells
In force
 · High confidence
Eyepoint, Inc.In forceHigh confidence
US 9,486,459Porous Silicon Drug-Eluting Particles
In force
 · Medium confidence
Eyepoint, Inc.In forceMedium confidence
US 9,962,396Porous silicon drug-eluting particles
In force
 · High confidence
Eyepoint, Inc.In forceHigh confidence
US 9,023,896Porous Silicon Drug-Eluting Particles
In force
 · High confidence
Eyepoint, Inc.In forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited